March 18, 2020 / 6:37 AM / 12 days ago

BRIEF-Xvivo Perfusion Updates On Covid-19 Effect On Xvivo Perfusion

March 18 (Reuters) - Xvivo Perfusion AB:

* THE COVID-19 EFFECT ON XVIVO PERFUSION

* XVIVO PERFUSION SEES A DECLINE IN DEMAND FOR TRANSPLANT PRODUCTS DUE TO COVID-19 EPIDEMIC FOR AT LEAST NEXT QUARTER BUT SEES NO LONG-TERM IMPACT ON DEMAND

* PLANNED START OF CLINICAL TRIALS IN EUROPE HAS BEEN DELAYED

* AN ACTION PROGRAM IS NOW BEING IMPLEMENTED TO REDUCE EXPENDITURE

* COMPANY ESTIMATES THAT SALES DURING Q1 WILL BE APPROXIMATELY 15 PERCENT LESS THAN LAST YEAR Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below